It can take years before scientists understand how a basic research discovery will impact the clinical care of cancer patients. IU Simon Comprehensive Cencer Center is committed to following these discoveries from the laboratory to the clinical environment and back.
Read about the latest research developments, faculty appointments and other cancer center news.
Our work is driven by constant reminders that #ResearchCuresCancer. Follow us on social media to learn about our latest advances in life-saving cancer research and news from the IU Simon Comprehensive Cancer Center.
Four hundred women donated healthy breast tissue to the Indiana University Melvin and Bren Simon Comprehensive Cancer Center's Susan G. Komen Tissue Bank, a resource within the Vera Bradley Foundation Center for Breast Cancer Research at the cancer center, during the July 12-13 bold endeavor.
Led by Jiang Bian, PhD, the retrospective study found taking GLP-1s was associated with lowered risks for endometrial, ovarian and meningioma cancers. Bian and colleagues published these findings in the journal JAMA Oncology this summer.
A clinical trial at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center could improve quality of life for men with prostate cancer. IU is among the first cancer centers to enroll patients in the study, which is evaluating an implantable device designed to help men regain urinary control following prostate removal surgery.
Indiana University School of Medicine has appointed John J. Turchi, PhD, as chair of the newly merged Department of Biochemistry, Molecular Biology and Pharmacology. He will assume the role effective Oct. 1.
